1)- Can Hou, Yong Wang, Yanjun Wang, Yaqing Zhou, Lei Hua, Jiaxin Chen, Shu He, Sheng Zhang, Enzhi Jia. Circular RNA expression profile of HO induced ferroptosis model of human coronary artery endothelial cells.Atherosclerosis plus. 2022, 49: 1-11
2)- Fangyuan Li, Pucong Ye, Yu Hao, Juan Du, Hang Zhang, Zengtao Wang, Xumin Wang, Hui Zeng, Yaluan Ma, Jie Lin. A PCSK9 inhibitor induces a transient decrease in the neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in homozygous familial hypercholesterolemia patients.Atherosclerosis plus. 2022, 49: 12-19
3)- Laura H Gunn, Ailsa J McKay, Amy Feng, Michael J Louie, Christie M Ballantyne, Kausik K Ray. Estimated cardiovascular benefits of bempedoic acid in patients with established cardiovascular disease.Atherosclerosis plus. 2022, 49: 20-27
4)- Margareta Fistrek Prlic, Marijana Coric, Laura Calabresi, Chiara Pavanello, Lorena Mosca, Ugo Cavallari, Ivana Vukovic Brinar, Sandra Karanovic, Mario Laganovic, Bojan Jelakovic. Two novel variants in the lecithin:cholesterol acyltransferase gene resulted in classic LCAT deficiency.Atherosclerosis plus. 2022, 49: 28-31
5)- Ditte Marie Jensen, Gry Freja Skovsted, Mathilde Frederikke Bjørn Bonde, Jacob Fog Bentzon, Bidda Rolin, Grégory Franck, Maria Katarina Elm Ougaard, Louise Marie Voetmann, Julian Christoffer Bachmann, Anna Uryga, Charles Pyke, Rikke Kaae Kirk, Henning Hvid, Lotte Bjerre Knudsen, Jens Lykkesfeldt, Michael Nyberg. Semaglutide treatment attenuates vessel remodelling in ApoE-/- mice following vascular injury and blood flow perturbation.Atherosclerosis plus. 2022, 49: 32-41
7)- Isabella Ramos Lima, Mauricio Teruo Tada, Theo G M Oliveira, Cinthia Elim Jannes, Isabela Bensenor, Paulo A Lotufo, Raul D Santos, Jose E Krieger, Alexandre C Pereira. Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort.Atherosclerosis plus. 2022, 49: 47-55